American Journal of Ophthalmology
Volume 141, Issue 6 , Pages 1061-1067.e1 , June 2006

Progression of Visual Field Defects in Leber Hereditary Optic Neuropathy: Experience of the LHON Treatment Trial

  • Nancy J. Newman, MD

      Affiliations

    • Department of Ophthalmology, Emory University School of Medicine, Atlanta, Georgia
    • Department of Neurology, Emory University School of Medicine, Atlanta, Georgia
    • Department of Neurological Surgery, Emory University School of Medicine, Atlanta, Georgia
    • Corresponding Author InformationInquiries to Nancy J. Newman, MD, Neuro-Ophthalmology Unit, Emory Eye Center, 1365-B Clifton Road NE, Atlanta, GA 30322
    • ,
  • Valérie Biousse, MD

      Affiliations

    • Department of Ophthalmology, Emory University School of Medicine, Atlanta, Georgia
    • Department of Neurology, Emory University School of Medicine, Atlanta, Georgia
    • ,
  • Steven A. Newman, MD

      Affiliations

    • Department of Ophthalmology, University of Virginia, Charlottesville, Virginia
    • ,
  • M. Tariq Bhatti, MD

      Affiliations

    • Departments of Ophthalmology, Neurology, and Neurosurgery, University of Florida, Gainesville, Florida
    • ,
  • Steven R. Hamilton, MD

      Affiliations

    • Swedish Neuroscience Institute, Seattle, Washington
    • ,
  • Bradley K. Farris, MD

      Affiliations

    • Dean A. McGee Eye Institute, Oklahoma City, Oklahoma
    • ,
  • Robert L. Lesser, MD

      Affiliations

    • Departments of Ophthalmology and Visual Science and Neurology, Yale University School of Medicine, New Haven, Connecticut
    • ,
  • Roger E. Turbin, MD

      Affiliations

    • Institute of Ophthalmology and Visual Sciences, University of Medicine and Dentistry of New Jersey, Newark, New Jersey

,Accepted 22 December 2005.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 N.J.N. acted as a consultant for Allergan Inc.Supported in part by Allergan Inc, Irvine, California. N.J.N. and V.B. were supported in part by a departmental grant (Department of Ophthalmology) from Research to Prevent Blindness Inc, New York, New York, and by core grant P30-EY06360 (Department of Ophthalmology) from the National Institutes of Health, Bethesda, Maryland. N.J.N. is a recipient of a Research to Prevent Blindness Lew R. Wasserman Merit Award. R.E.T.’s work was supported by the Gene C. Coppa Memorial Fund.

PII: S0002-9394(06)00018-3

doi: 10.1016/j.ajo.2005.12.045

American Journal of Ophthalmology
Volume 141, Issue 6 , Pages 1061-1067.e1 , June 2006

Article Tools

* Image Usage & Resolution